NWBO
OQB Northwest Biotherapeutics, Inc.$0.1537 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1537, and at the day’s high of $0.1571
- YTD change
- -32.81%
- vs 20-day SMA
- -5.51%
- vs 200-day SMA
- -27.11%
Price ranges
Price & Performance
-0.05 (-24.40%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 93.9% away from all-time highs of $2.5100
- NWBO is down 33% since the beginning of the year
- NWBO is down 37% over the past 12 months
- NWBO is down 9% over the past 1 month
- 5% of all NWBO investors are betting against NWBO
NWBO reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -39.1%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0020
- Last 5 days
- -3.70%
- vs 8-day SMA
- -1.28%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
